Map of Mifepristone Approvals

Gynuity Health Projects monitors the approval status of mifepristone across the globe. The map provided reflects our most recent information about where the medication is available. If you notice any inaccuracies or learn of new approvals, you are encouraged to contact us at pubinfo@gynuity.org.

Mifepristone was approved for use in France in 1988, the United Kingdom in 1991 and Sweden in 1992. In the United States, the Food and Drug Administration approved mifepristone for pregnancy termination in 2000. Most recently, Tanzania became the latest country to authorize use of mifepristone, with its Medicines and Medical Devices Registration Authority granting approval in 2024.

Mifepristone is most commonly known for its use to terminate a pregnancy. It functions by reducing the biological availability of progesterone, a hormone essential for maintaining pregnancy. For effective results, it is used in combination with misoprostol, which induces uterine contractions to facilitate emptying of the uterus.

Mifepristone is used for alternative indications, including the treatment of early pregnancy loss and intrauterine fetal demise.